Massimo Doris, CEO of Banca Mediolanum buys 2% of the share package, creating a partnership with the company specializing in the production of new biomaterials derived from hyaluronic acid.
Torviscosa - BMG Pharma reaches patent record
A business plan focused on commercial expansion, research and development. In two years, the company created 4 new patents and registered 36 innovative products, as well as launching 37 on an international scenario.
